Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination-Reference-Cited by-同舟云学术

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination

Published:2015-07-17 Issue:11 Volume:29 Page:1345-1354
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Bhorat As’ad E.,Madhi Shabir A.,Laudat France,Sundaraiyer Vani,Gurtman Alejandra,Jansen Kathrin U.,Scott Daniel A.,Emini Emilio A.,Gruber William C.,Schmoele-Thoma Beate

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference36 articles.

1. The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease.;Bliss;Lancet Infect Dis,2008

2. Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program.;Nunes;PLoS One,2011

3. The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis.;Nunes;AIDS,2011

4. Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi.;Everett;PLoS One,2011

5. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000.;Heffernan;J Infect Dis,2005

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A System Intervention to Increase Pneumococcal Vaccination Rates in Adults Living With Human Immunodeficiency Virus Who Present for Scheduled Medical Care;Journal of the Association of Nurses in AIDS Care;2024-06-04

2. Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023;MMWR. Recommendations and Reports;2023-09-08

3. Predictors of serological non-response to the 13-valent pneumococcal conjugate vaccine followed by the 23-valent polysaccharide vaccine among adults living with HIV;Vaccine;2023-07

4. Pneumococcal vaccination coverage at the initiation of chronic dialysis, and its association with mortality during the first year;Vaccine;2023-06

5. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines;Plotkin's Vaccines;2023